Apogee Therapeutics (APGE) News Today → Why June 30 Will Be the Tipping Point for AI (From Banyan Hill Publishing) (Ad) Free APGE Stock Alerts $41.69 -0.43 (-1.02%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 8 at 4:28 AM | marketbeat.comTD Asset Management Inc Buys 69,052 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE)TD Asset Management Inc grew its position in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 217.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 100,846 shares of the company's stock after purchasing an additional 69,052June 8 at 3:36 AM | americanbankingnews.comApogee Therapeutics (APGE) & Its Rivals Head to Head ReviewJune 5 at 10:28 AM | marketbeat.comAffinity Asset Advisors LLC Reduces Holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE)Affinity Asset Advisors LLC decreased its position in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 48.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 537,093 shares of the company's stock aftMay 31, 2024 | marketbeat.comSwiss National Bank Makes New $922,000 Investment in Apogee Therapeutics, Inc. (NASDAQ:APGE)Swiss National Bank bought a new stake in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 33,000 shares of the company's stock, valued at aMay 29, 2024 | americanbankingnews.comApogee Therapeutics, Inc. (NASDAQ:APGE) Receives Average Rating of "Buy" from AnalystsMay 28, 2024 | globenewswire.comApogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MDMay 27, 2024 | finance.yahoo.comHere's Why We're Not Too Worried About Apogee Therapeutics' (NASDAQ:APGE) Cash Burn SituationMay 27, 2024 | marketbeat.comFranklin Resources Inc. Purchases 92,423 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE)Franklin Resources Inc. boosted its stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 9.3% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 1,089,780 shares of the company's stock after buying an additional 92,423 shares duriMay 23, 2024 | globenewswire.comApogee Therapeutics to Participate in Upcoming June Investor ConferencesMay 23, 2024 | marketbeat.comJump Financial LLC Buys Shares of 18,344 Apogee Therapeutics, Inc. (NASDAQ:APGE)Jump Financial LLC purchased a new position in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 18,344 shares of the company's stock, valued at aMay 17, 2024 | marketbeat.comApogee Therapeutics (NASDAQ:APGE) Shares Down 4% Apogee Therapeutics (NASDAQ:APGE) Trading Down 4%May 15, 2024 | globenewswire.comApogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory DiseasesMay 15, 2024 | marketbeat.comBrokers Issue Forecasts for Apogee Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:APGE)Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) - Analysts at Wedbush upped their Q2 2024 earnings per share estimates for shares of Apogee Therapeutics in a research note issued to investors on Monday, May 13th. Wedbush analyst D. Nierengarten now anticipates that the company will post earMay 14, 2024 | marketbeat.comApogee Therapeutics (NASDAQ:APGE) Sees Large Volume IncreaseApogee Therapeutics (NASDAQ:APGE) Sees Strong Trading VolumeMay 14, 2024 | marketbeat.comResearch Analysts Issue Forecasts for Apogee Therapeutics, Inc.'s Q1 2025 Earnings (NASDAQ:APGE)Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) - Equities researchers at Wedbush issued their Q1 2025 EPS estimates for Apogee Therapeutics in a research note issued to investors on Monday, May 13th. Wedbush analyst D. Nierengarten anticipates that the company will post earnings of ($0.63)May 14, 2024 | markets.businessinsider.comBuy Rating on Apogee Therapeutics: Promising Drug Developments and Strong FinancialsMay 13, 2024 | marketbeat.comApogee Therapeutics (NASDAQ:APGE) Stock Rating Reaffirmed by WedbushWedbush reaffirmed an "outperform" rating and issued a $87.00 price target on shares of Apogee Therapeutics in a research report on Monday.May 13, 2024 | investorplace.comAPGE Stock Earnings: Apogee Therapeutics Misses EPS for Q1 2024May 13, 2024 | globenewswire.comApogee Therapeutics Highlights Pipeline Progress and Reports First Quarter 2024 Financial ResultsMay 11, 2024 | nasdaq.comB of A Securities Initiates Coverage of Apogee Therapeutics (APGE) with Buy RecommendationMay 10, 2024 | marketbeat.comApogee Therapeutics (NASDAQ:APGE) Now Covered by Bank of AmericaBank of America began coverage on Apogee Therapeutics in a research note on Friday. They issued a "buy" rating and a $80.00 price target for the company.May 8, 2024 | investorplace.comEarnings Superstars: 3 Stocks Primed to Outperform This QuarterMay 6, 2024 | globenewswire.comApogee Therapeutics to Participate at the 2024 Bank of America Healthcare ConferenceApril 27, 2024 | marketbeat.comJennison Associates LLC Invests $2.90 Million in Apogee Therapeutics, Inc. (NASDAQ:APGE)Jennison Associates LLC acquired a new stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 103,744 shares of the company's stock,April 24, 2024 | marketbeat.comApogee Therapeutics (NASDAQ:APGE) Trading Down 6.2%Apogee Therapeutics (NASDAQ:APGE) Stock Price Down 6.2%April 18, 2024 | marketbeat.comApogee Therapeutics (NASDAQ:APGE) Trading Down 6.1%Apogee Therapeutics (NASDAQ:APGE) Shares Down 6.1%April 17, 2024 | marketbeat.comApogee Therapeutics (NASDAQ:APGE) Stock Price Up 3.3%Apogee Therapeutics (NASDAQ:APGE) Shares Up 3.3%April 16, 2024 | finance.yahoo.comWith 54% institutional ownership, Apogee Therapeutics, Inc. (NASDAQ:APGE) is a favorite amongst the big gunsApril 15, 2024 | finance.yahoo.comApogee Therapeutics, Inc. (APGE)April 14, 2024 | marketbeat.comVanguard Group Inc. Makes New Investment in Apogee Therapeutics, Inc. (NASDAQ:APGE)Vanguard Group Inc. acquired a new stake in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 1,121,764 shares of the companApril 12, 2024 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Short Interest UpdateApogee Therapeutics, Inc. (NASDAQ:APGE - Get Free Report) saw a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 4,600,000 shares, a growth of 50.8% from the March 15th total of 3,050,000 shares. Approximately 13.1% of the shares of the company are sold short. Based on an average trading volume of 680,700 shares, the days-to-cover ratio is currently 6.8 days.April 11, 2024 | marketbeat.comApogee Therapeutics (NASDAQ:APGE) Trading Up 7%Apogee Therapeutics (NASDAQ:APGE) Trading Up 7%April 9, 2024 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Receives Average Recommendation of "Buy" from BrokeragesShares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Get Free Report) have been assigned an average rating of "Buy" from the seven ratings firms that are currently covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation. The average 12-month pricApril 8, 2024 | marketbeat.comApogee Therapeutics (NASDAQ:APGE) Stock Price Down 3.2%Apogee Therapeutics (NASDAQ:APGE) Trading Down 3.2%April 2, 2024 | marketbeat.comApogee Therapeutics (NASDAQ:APGE) Trading Down 9.1%Apogee Therapeutics (NASDAQ:APGE) Stock Price Down 9.1%March 29, 2024 | finance.yahoo.comKey Proteo Submits De Novo Application to FDA for its First Newborn Screening KitMarch 28, 2024 | msn.comGov. Youngkin vetoes bills that would legalize retail marijuana sales, increase minimum wageMarch 28, 2024 | finance.yahoo.comUS FDA extends review of Applied Therapeutics' genetic disease drugMarch 27, 2024 | markets.businessinsider.comBuy Rating Affirmed for Apogee Therapeutics as APG777 Shows Promise and Pipeline ProgressesMarch 25, 2024 | globenewswire.comApogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory DiseasesMarch 22, 2024 | marketbeat.comTeachers Retirement System of The State of Kentucky Takes $474,000 Position in Apogee Therapeutics, Inc. (NASDAQ:APGE)Teachers Retirement System of The State of Kentucky purchased a new stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 22,248 shares of the compMarch 18, 2024 | marketbeat.comShort Interest in Apogee Therapeutics, Inc. (NASDAQ:APGE) Declines By 5.2%Apogee Therapeutics, Inc. (NASDAQ:APGE - Get Free Report) was the recipient of a large decrease in short interest in February. As of February 29th, there was short interest totalling 3,130,000 shares, a decrease of 5.2% from the February 14th total of 3,300,000 shares. Approximately 14.6% of the company's stock are sold short. Based on an average trading volume of 513,400 shares, the short-interest ratio is presently 6.1 days.March 15, 2024 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Given Average Rating of "Buy" by AnalystsApogee Therapeutics, Inc. (NASDAQ:APGE - Get Free Report) has been assigned an average recommendation of "Buy" from the seven brokerages that are covering the company, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy rating. The average twelve-month target price among broMarch 14, 2024 | benzinga.comTop 3 Health Care Stocks That Are Ticking Portfolio BombsMarch 13, 2024 | marketbeat.comApogee Therapeutics (NASDAQ:APGE) Hits New 1-Year High at $71.80Apogee Therapeutics (NASDAQ:APGE) Sets New 52-Week High at $71.80March 13, 2024 | seekingalpha.comARM: Everything You Need To Know About The Lock-Up Expiry (Rating Upgrade)March 12, 2024 | finance.yahoo.comApogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $483 MillionMarch 12, 2024 | globenewswire.comApogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $483 MillionMarch 10, 2024 | marketbeat.comAdage Capital Partners GP L.L.C. Buys Shares of 375,000 Apogee Therapeutics, Inc. (NASDAQ:APGE)Adage Capital Partners GP L.L.C. bought a new stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 375,000 shares of the company's stock, valued at approximatMarch 8, 2024 | msn.comApogee Therapeutics stock slides on pricing upsized stock offering to raise $420 million Get Apogee Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Top 5 Tech Stocks to Buy for 2024 (Ad)The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution… Click below for your free report "Top 5 Tech Stocks to Buy in 2024", APGE Media Mentions By Week APGE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APGE News Sentiment▼1.210.72▲Average Medical News Sentiment APGE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APGE Articles This Week▼32▲APGE Articles Average Week Get Apogee Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RGEN News Today PCVX News Today EXEL News Today RVMD News Today HALO News Today CRSP News Today KRYS News Today IBRX News Today IMVT News Today TWST News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APGE) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredThe new masters of energyAccording to one source, this new grid could soon provide energy to “one billion people in the world who don’t...Porter & Company | SponsoredWe’ve Made 1,000% … THREE Different Times in the Last Year (Here’s How)Bitcoin can and probably will hit the $1 MILLION level this decade. That’s more than 1,000% upside from the...Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | Sponsored